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The leukocyte common antigen (L-CA in  the rat,  T200  in the mouse) is a 
family of high  Mr  glycoproteins that  are  present  exclusively on  cells  of the 
hematopoietic lineage (1,  2),  excluding mature erythroid cells (3).  Functional 
studies using mAbs have implicated L-CA in a number of immunologic processes, 
including NK- (4) and CTL-induced cytolysis (5),  B cell differentiation (6), and 
regulation  of IL-2  receptor expression  (7).  In  addition,  L-CA-specific mAbs 
provided the first means to  distinguish  between functional subpopulations  of 
helper T  cell (T) in the rat (8).  Although L-CA is expressed on all leukocytes, 
different classes of leukocytes express different forms of the molecule, and this 
pattern is conserved between species. For example, thymocyte L-CA appears to 
consist predominantly of a  single major component, whereas peripheral T  cell 
L-CA can be resolved into three or four species, and B cell L-CA constitutes an 
additional distinct high molecular weight form (9). 
Recently, cDNA clones encoding rat L-CA from thymus and purified B cells 
have been isolated, and from the sequence of the thymocyte cDNA clones, a 
partial  primary structure  of  1,073  amino  acids  has  been  deduced (10).  The 
region likely to be the membrane spanning segment was found at residues 347- 
368, and the sequence amino-terminal to this was found to be on the extracellular 
side. This suggests that there is a cytoplasmic domain of 705 amino acids. The 
isolated  B  cell  cDNA  clones  encompassed  the  region  from  the  membrane- 
spanning segment to the polyadenylation signal. The partial sequence of the B 
cell cDNA clones indicated complete identity between the 3' regions of thymo- 
cyte and B cell L-CA, implying that they have identical cytoplasmic domains and 
that these two forms of L-CA are encoded by the same gene. However, Northern 
blot analysis shows thymocyte mRNA to be 4.8 kb, whereas B cell mRNA is 5.5 
kb.  This  suggested  that  differential  RNA  processing  may contribute  to  the 
heterogeneity in the forms of L-CA expressed on the surface of different classes 
of lymphocytes. In the mouse, mAbs have been described that are reactive only 
with the T200 glycoprotein expressed on cytotoxic T  cells (11,  12). The deter- 
minants recognized by these antibodies,  termed CT  antigens,  are dependent 
upon carbohydrate moieties displayed on the molecule (13). This finding estab- 
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lishes  that  during  T  cell  development,  changes  occur  in  the  oligosaccharides 
found on the T200 glycoprotein. However, this does not exclude alterations in 
protein structure.  In fact, the different patterns of glycosylation may be deter- 
mined by such modifications. Here we show that cloned murine cytotoxic and 
helper T  cell lines express T200 mRNAs that differ in size, and that differences 
in Mr of the newly synthesized T200  glycoprotein in the two cell types can be 
detected.  Together,  these  data  suggest  that  the  primary  structure  of T200 
glycoprotein on activated cytotoxic T  cells differs from that found on activated 
Th cells. 
Materials and Methods 
Northern  Blot  Analysis  of L-CA  mRNA.  Total  RNA  was  isolated  from  cells  using 
guanidium isothiocyanate lysis and centrifugation over a  cesium chloride cushion (14). 
Poly-A ÷ RNA was selected by a single passage over oligo(dT)-cellulose.  RNA was electro- 
phoresed on a 0.5% Agarose gel containing formaldehyde and blotted onto Zetaprobe 
(BioRad Laboratories, Richmond, CA) as previously described (10). Prehybridization and 
hybridization were by the method of Gatti et al. (15). The probe used was a 3.7 kb Eco 
RI fragment from the rat thymocyte  cDNA clone pLC-2 or a single-stranded rat thymocyte 
cDNA transcribed from a  M13 clone and corresponding to position 1,110-1,621  (10). 
The filter was washed in 30 mM sodium citrate, pH 7, 0.3 M NaCI, 0.1% SDS at 52°C, 
and used to expose Kodak X-OMAT AR-5 film. 
Radiolabeling and Immunoprecipitation of T200 Proteins.  These procedures are essen- 
tially as previously described (15). Briefly, cells were labelled with [sSS]methionine  for 5 
rain and subsequently lysed. After centrifugation and preclearing, the resulting superna- 
tant was incubated with anti-T200 mAb I3/2.3 coupled to Sepharose 4B. For treatment 
with endoglycosidase H (Miles Laboratories, Inc., Naperville, IL), the washed precipitates 
were boiled in 50 mM Tris-HCl, pH 6.8, and 0.1% SDS, followed by the addition of 0.15 
M sodium citrate, pH  5.5, with or without the addition of the enzyme. Digestion was 
carried out for 16 h at 37 °C. The precipitates were then analyzed by SDS-PAGE. 
Results and Discussion 
To compare the T200  mRNA made by activated CTL and Th cells, poly-A  + 
RNA  was  isolated  from  several  cloned  murine  CTL  and  Th  cell  lines  and 
subjected to Northern blot analysis using a rat L-CA cDNA probe (10). As shown 
in Fig.  1 a, a small but consistent difference in the size of T200 mRNA isolated 
from the CTL and Th cell lines was detected. The mRNA encoding T200 from 
three CTL lines was estimated to be 5.2 kb, and was larger than that from each 
of four Th cell lines, which was 4.8 kb. This difference in size was observed for 
all of the CTL and Th  clones analyzed, regardless of their strain of origin or 
antigen specificity. For comparison, mRNA from thymus, lymph node T  cells, 
and a  pre-B cell line, 70Z/3  (16), were also analyzed. B cell T200  was encoded 
by a 5.5 kb mRNA and was significantly larger than thymocyte T200 mRNA, as 
previously reported  for  L-CA  mRNA  isolated  from  rat  B  lymphocytes (10). 
These findings are highly reproducible, and the results of a  second experiment 
are shown in Fig.  1 b.  Northern blot analysis of the same gels using a probe for 
the/3-chain  of the T  cell receptor revealed no variation in size of the  mRNA 
from the various T  cell types (data not shown). It is concluded that there are at 
least three different T200  mRNAs, and that CTL, Th cells, and B  cells each 
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FIGURE  1.  Northern blot analysis of L-CA mRNA from various mouse leukocytes. RNA was 
fractionated on a 0.5% agarose formaldehyde gel and blotted onto Zetaprobe (Biorad Labo- 
ratories). The filter was hybridized with a 3.7 kb Eco RI probe from the rat thymocyte cDNA 
clone pHC-2 (a) or a single-stranded rat thymocyte cDNA transcribed from a M13 clone and 
corresponding  to position  I,I 10-1,621  (b) (10). In a, lane 1, RNA was from lymph node T 
cells isolated by depleting  B cells with the mAb J 11 D plus complement (25); lanes 2-4 RNA 
from the CTL clones B3, 8.2, and H7, respectively; lane 5 RNA from the pre-B cell line 
70Z/3;  lane 6,  from thymocyte  RNA;  lanes 7-10,  Th  RNA  from K3, BB5, K31C7, and 
K321C9, respectively (Th lines were generously provided  by Dr. Andrew Glasebrook, The 
Salk Institute, and Dr. Susan Webb, Scipps Clinic and Research Foundation). In b, RNA was 
from: lane 1, CTL clone H7; lane 2, pre-B cell line 70Z/3; lane 3, Th clone K3.3. 
The T200  glycoprotein expressed on the  surface of CTL  is larger than  that 
found  on  Th  cells,  thymocytes, and  lymph node  T  cells,  and  this  is  consistent 
with the difference in the size of T200  glycoprotein mRNA  found in these cell 
types.  However,  the  mature  glycoprotein  is  heavily  glycosylated,  and  there  is 
compelling evidence that the oligosaccharide structures  displayed by the T200 
glycoproteins on the surface of CTL and Th cells are not identical and contribute 
to the heterogeneity in size observed (13). To determine whether the precursors 
of the  T200  glycoproteins in  CTL  and  Th  cells at  the  earliest time detectable 
after  synthesis  differ  in  size,  cells  were  pulse-labeled  for  5  min  with  [SsS]- 
methionine and the T200  proteins were isolated by immunoprecipitation.  Var- 
ious  precursor  forms of T200  glycoprotein  characteristic  of each  lymphocyte 
population are evident as shown in Fig. 2. Even at this early time point there are 
at least three species of T200 for CTLs and for lymph node T  cells. The B  cell 
T200 is identified by the presence of a  protein of high Mr in unseparated lymph 
node cells that is absent after removal of B  cells (Fig.  2,  compare lanes 3  and 5 
and  6).  Treatment  of the  isolated  proteins  with  endoglycosidase  H  (endo  H) 
showed  that  all  of  the  precursor  molecules  contain  high  mannose  N-linked 
oligosaccharides (17).  However, even after removal of the  high-mannose oligo- 
saccharides, the same heterogeneous pattern of T200 species is seen.  In the case 
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FIGURE 2.  Immunoprecipitation of T200 precursor proteins. Thymocytes (lanes 1 and 2), 
lymph node T cells (lanes 3 and 4), unseparated lymph node cells (lanes 5 and 6), CTL clone 
H7 (lanes 7 and 8), and Th clone BB5 (lanes 9 and 10) were pulse-labeled  with [sSS]methionine 
for 5 rain. The cells were lysed and irnmunoprecipitation  was carried out using I3/2.3 (anti- 
T200) coupled to Sepharose 4 B. lmmunoprecipitates from each lysate were divided in half 
and treated with endo H (lanes  2,  4, 6, 8,  10) or mock-treated (lanes 1,  3, 5,  7,  9) for 16 h at 
37 °  C, followed  by analysis  on a 7.5% S  DS-polyacrylamide  gel. 
(13).  It is also unlikely that the addition of O-linked oligosaccharides contributes 
to  the  heterogeneity of the  T200  precursors,  as  this  is  known  to  occur  as  a 
relatively late event in the biosynthesis of membrane glycoproteins (18). 
There is a  clear correlation between the size of the T200  mRNA transcripts 
made  by  the  various  cell  types  and  the  Mr  of the  newly  synthesized  T200 
molecules. This supports the notion that the mRNAs encode T200 glycoproteins 
with a  different primary structure.  However, only a  single mRNA species was 
detected  in each cell  type, whereas  multiple precursor  protein  species are  ob- 
served in some cells. It is possible that other differential posttranslational modi- 
fications of the newly synthesized glycoproteins, including proteolytic cleavage, 
may occur.  Sequence analysis will be required  to determine the precise differ- 
ences.  How the various forms of T200  mRNA are generated is unknown, but 
could be the result of alternate splicing of a common RNA precursor (19, 20) or 
use of alternate transcription initiation sites (21). 
The precise role of the T200  glycoprotein in lymphocyte interactions is still 
obscure.  It is possible  that cell type-specific T200  determinants play a  role in 
lymphocyte homing to  particular  immunologic sites.  Previous  results  (13-15) 
indicate that certain oligosaccharide moieties (termed CT antigens) that are likely 
to be O-linked are added to the T200 proteins of activated CTL and not to the 
T200 proteins of activated Th or any other T200 proteins. A strong correlation 
was noted between the presence of the CT antigens and cytotoxic activity (11, 
12,  22).  A  large  portion  (705  amino  acids)  of the  T200  molecule  is  on  the 
cytoplasmic side of the plasma membrane,  suggesting involvement of T200  in 
transmembrane signaling perhaps via cytoskeletal interactions (23). Since, in the 
rat, the cDNAs from thymocytes and B cells encoding the intracellular domain 
of the molecule are identical (10), it is likely that any cell type-specific differences 
in primary structure of T200  glycoprotein will be in the extracellular domain. 
The programmed expression of different forms of T200 glycoprotein during B LEFRAN~OIS ET  AL  BRIEF  DEFINITIVE REPORT  1341 
and T  cell development is highly conserved across species, and thus is likely to 
have important consequences for lymphocyte function. 
A cDNA clone from the mouse has recently been reported (24), and consistent 
with the results reported here, Northern blot analysis showed size differences in 
the T200 mRNAs isolated from T  and B leukemic cell lines. 
Summary 
The leukocyte common antigen, T200,  is expressed on all white blood cells 
but not on other differentiated cells. Within the hematopoietic lineage, specific 
cell types display characteristic structural forms of the molecule on their surface. 
We show that murine cytotoxic T  lymphocyte clones and helper T  cell clones 
contain different size mRNA for this molecule, and that the early precursors of 
T200 glyeoprotein made in the helper and cytotoxic T  cells differ in Mr. Thus, 
in addition to differences in posttranslational  modifications, it is highly likely 
that a  difference in protein structure contributes to the distinct forms of T200 
glycoprotein found on these functional T  cell subsets. 
Received  for publication 19 December 1985 and in revised  form 20 February 1986. 
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